Radiation boost may help CAR-T cells fight tough lymphoma
NCT ID NCT05514327
First seen Mar 28, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests whether a special type of radiation given in very small, frequent doses before CAR-T cell therapy can safely and effectively treat people with relapsed or refractory diffuse large B-cell lymphoma. About 20 adults who have not responded to at least two prior treatments will receive this radiation followed by CAR-T infusion. The main goal is to see how many patients respond within 3 months, with longer-term outcomes tracked over 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.